Infect Chemother.  2016 Jun;48(2):71-74. 10.3947/ic.2016.48.2.71.

Collaborative Intervention of Middle East Respiratory Syndrome: Rapid Response Team

• Lee J
• Rapid Response Team
• Kim WJ

• KMID: 2327973
• DOI: http://doi.org/10.3947/ic.2016.48.2.71

Abstract

On May 20th 2015, a 68 year old man was the first to be diagnosed with Middle East Respiratory Syndrome-Corona Virus (MERS-CoV) in Korea. He travelled to Bahrain, Saudi Arabia, and Qatar for 16 days. On May 4th 2015, the patient entered Korea, with febrile sense and respiratory symptoms that appeared on May 11th. The MERS-CoV Outbreak became worse and several patients had to be admitted throughout various hospitals starting at the beginning of June. This situation led to a nationwide chaos. The Rapid Response Team (RRT) was organized after the Korean government's calling for specialists that were composed of 15 Infectious disease Doctors and 2 Infection Control professionals on the 8th of June 2015. The main purpose of the RRT were: 1) consultation to the Government controlling MERS-CoV outbreak. 2) Visit hospitals that were exposed to MERS-CoV infected patients, and to provide advice regarding infection control strategy for rehabilitating of the exposed hospitals. Since June 8th, the RRT visited more than 10 hospitals and an effective consultation was carried out. Most of the hospitals were recovering from the MERS outbreak since early July. Cooperation between the government and private sector experts was very effective. The efforts of government and private sector experts overcame the initial chaos situation. It could prevent further deterioration of the MERS outbreak.

Keyword

Middle East Respiratory Syndrome; Coronavirus; Outbreak control

MeSH Terms

Bahrain
Communicable Diseases
Coronavirus
Coronavirus Infections*
Humans
Infection Control
Korea
Middle East Respiratory Syndrome Coronavirus
Middle East*
Private Sector
Qatar
Saudi Arabia
Specialization

Reference

1. Lee J. Better understanding on MERS corona virus outbreak in Korea. J Korean Med Sci. 2015; 30:835–836.

2. Korean Society of Infectious Diseases. Korean Society for Healthcare-associated Infection Control and Prevention. The same Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) yet different outbreak patterns and public health impacts on the far east expert opinion from the rapid response team of the Republic of Korea. Infect Chemother. 2015; 47:247–251.

3. Chong YP, Song JY, Seo YB, Choi JP, Shin HS. Rapid Response Team. Antiviral treatment guidelines for Middle East Respiratory Syndrome. Infect Chemother. 2015; 47:212–222.

4. Kim JY, Song JY, Yoon YK, Choi SH, Song YG, Kim SR, Son HJ, Jeong SY, Choi JH, Kim KM, Yoon HJ, Choi JY, Kim TH, Choi YH, Kim HB, Yoon JH, Lee J, Eom JS, Lee SO, Oh WS, Choi JH, Yoo JH, Kim WJ, Cheong HJ. Middle East Respiratory Syndrome infection control and prevention guideline for healthcare facilities. Infect Chemother. 2015; 47:278–302.

5. Lee H, Ki CS, Sung H, Kim S, Seong MW, Yong D, Kim JS, Lee MK, Kim MN, Choi JR, Kim JH. Korean Society for Laboratory Medicine MERS-CoV Task Force. Guidelines for the laboratory diagnosis of Middle East Respiratory Syndrome Coronavirus in Korea. Infect Chemother. 2016; 48:61–69.